Search research articles
Contact Us
Filters
Showing results (11-20 of 29) with videos related to
Page
of 3
Sort By:
The Journal of Biological Chemistry
|
June 22, 2021
Molecular determinants for α-tubulin methylation by SETD2
Sarah Kearns, Frank M Mason, W Kimryn Rathmell, et al.
Cancer Research
|
April 30, 2026
SETD2 Deficiency Drives Mitochondrial DNA Leakage and Creates a Druggable Dependency on BCL-XL in Clear Cell Renal Cell Carcinoma
Anusha Uprety, Chandler Judd, Emily D Villella, et al.
Biorxiv : the Preprint Server for Biology
|
March 11, 2024
Lysine Demethylase 4A is a Centrosome Associated Protein Required for Centrosome Integrity and Genomic Stability
Pratim Chowdhury, Xiaoli Wang, Julia F Love, et al.
Breast Cancer Research : BCR
|
July 19, 2022
Combined Dusp4 and p53 loss with Dbf4 amplification drives tumorigenesis via cell cycle restriction and replication stress escape in breast cancer
Ann Hanna, Mellissa J Nixon, M Valeria Estrada, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
September 18, 2023
SETD2 safeguards the genome against isochromosome formation
Frank M Mason, Emily S Kounlavong, Anteneh T Tebeje, et al.
Cancers
|
March 14, 2026
Pharmacologic and Oncohistone Inhibition of SETD2 Converge on Genomic Instability
Alyssa T Paparella, Ashley G Boice, In Young Park, et al.
JCI Insight
|
August 21, 2020
CD28 costimulation drives tumor-infiltrating T cell glycolysis to promote inflammation
Kathryn E Beckermann, Rachel Hongo, Xiang Ye, et al.
The FEBS Journal
|
August 28, 2025
Lysine demethylase 4A is a centrosome-associated protein required for centrosome integrity and genomic stability
Pratim Chowdhury, Xiaoli Wang, Richard I Han, et al.
Science Advances
|
October 3, 2020
The Huntingtin-interacting protein SETD2/HYPB is an actin lysine methyltransferase
Riyad N H Seervai, Rahul K Jangid, Menuka Karki, et al.
Biorxiv : the Preprint Server for Biology
|
August 7, 2023
Drug screening in human physiologic medium identifies uric acid as an inhibitor of rigosertib efficacy
Vipin Rawat, Patrick DeLear, Prarthana Prashanth, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 29) with videos related to
Sort By:
Page
of 3
The Journal of Biological Chemistry
|
June 22, 2021
Molecular determinants for α-tubulin methylation by SETD2
Sarah Kearns, Frank M Mason, W Kimryn Rathmell, et al.
Cancer Research
|
April 30, 2026
SETD2 Deficiency Drives Mitochondrial DNA Leakage and Creates a Druggable Dependency on BCL-XL in Clear Cell Renal Cell Carcinoma
Anusha Uprety, Chandler Judd, Emily D Villella, et al.
Biorxiv : the Preprint Server for Biology
|
March 11, 2024
Lysine Demethylase 4A is a Centrosome Associated Protein Required for Centrosome Integrity and Genomic Stability
Pratim Chowdhury, Xiaoli Wang, Julia F Love, et al.
Breast Cancer Research : BCR
|
July 19, 2022
Combined Dusp4 and p53 loss with Dbf4 amplification drives tumorigenesis via cell cycle restriction and replication stress escape in breast cancer
Ann Hanna, Mellissa J Nixon, M Valeria Estrada, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
September 18, 2023
SETD2 safeguards the genome against isochromosome formation
Frank M Mason, Emily S Kounlavong, Anteneh T Tebeje, et al.
Cancers
|
March 14, 2026
Pharmacologic and Oncohistone Inhibition of SETD2 Converge on Genomic Instability
Alyssa T Paparella, Ashley G Boice, In Young Park, et al.
JCI Insight
|
August 21, 2020
CD28 costimulation drives tumor-infiltrating T cell glycolysis to promote inflammation
Kathryn E Beckermann, Rachel Hongo, Xiang Ye, et al.
The FEBS Journal
|
August 28, 2025
Lysine demethylase 4A is a centrosome-associated protein required for centrosome integrity and genomic stability
Pratim Chowdhury, Xiaoli Wang, Richard I Han, et al.
Science Advances
|
October 3, 2020
The Huntingtin-interacting protein SETD2/HYPB is an actin lysine methyltransferase
Riyad N H Seervai, Rahul K Jangid, Menuka Karki, et al.
Biorxiv : the Preprint Server for Biology
|
August 7, 2023
Drug screening in human physiologic medium identifies uric acid as an inhibitor of rigosertib efficacy
Vipin Rawat, Patrick DeLear, Prarthana Prashanth, et al.
Page
of 3